Panacea Biotec Limited(IN:PANACEABIO)
₹354.55-7.00 (-1.94%)
IN:PANACEABIO
Panacea Biotec Limited financials statements
₹354.55
At close:-7.00 (-1.94%)
Want to see IN:PANACEABIO full AI Analyst Report?
Panacea Biotec Limited (PANACEABIO) Financial Statements
0 Followers
Panacea Biotec Limited Financial Overview
Panacea Biotec Limited's market cap is currently ₹22.15B. The company's EPS TTM is ₹-1.16; its P/E ratio is -304.91; and it has a dividend yield of 0.56%. Panacea Biotec Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 6.40B | ₹ 5.59B | ₹ 5.52B | ₹ 4.57B | ₹ 6.59B |
| Gross Profit | ₹ 1.45B | ₹ 3.60B | ₹ 446.53M | ₹ 1.78B | ₹ 3.42B |
| Operating Income | ₹ -377.20M | ₹ -607.20M | ₹ -138.09M | ₹ -1.06B | ₹ -518.15M |
| EBITDA | ₹ -46.60M | ₹ 307.40M | ₹ 417.69M | ₹ 563.65M | ₹ 16.74B |
| Net Income | ₹ -53.70M | ₹ -83.70M | ₹ -11.73M | ₹ -332.37M | ₹ 10.78B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 744.00M | ₹ 1.79B | ₹ 1.56B | ₹ 2.13B | ₹ 5.52B |
| Total Assets | ₹ 12.62B | ₹ 12.90B | ₹ 12.41B | ₹ 12.71B | ₹ 17.59B |
| Total Debt | ₹ 236.60M | ₹ 222.10M | ₹ 209.90M | ₹ 202.19M | ₹ 341.55M |
| Net Debt | ₹ -407.10M | ₹ -599.20M | ₹ -261.80M | ₹ -196.33M | ₹ -161.95M |
| Total Liabilities | ₹ 4.33B | ₹ 4.59B | ₹ 4.02B | ₹ 4.31B | ₹ 8.85B |
| Stockholders' Equity | ₹ 8.35B | ₹ 8.35B | ₹ 8.42B | ₹ 8.44B | ₹ 8.77B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -367.50M | ₹ -776.80M | ₹ -778.18M | ₹ -4.63B | ₹ -1.21B |
| Operating Cash Flow | ₹ 173.40M | ₹ -273.70M | ₹ -1.00M | ₹ -4.22B | ₹ -1.08B |
| Investing Cash Flow | ₹ -455.70M | ₹ 649.80M | ₹ 102.27M | ₹ 4.30B | ₹ 12.83B |
| Financing Cash Flow | ₹ 33.70M | ₹ -26.60M | ₹ -28.08M | ₹ -183.73M | ₹ -11.76B |
Currency in INR
